ARAnnunziata Ilenia Ritacco

Annunziata Ilenia Ritacco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Annunziata Ilenia Ritacco has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Annalisa Saracino

    Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, 70124 Bari, Italy

    2 shared publications
  • Francesco Di Gennaro

    Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, 70124 Bari, Italy

    2 shared publications
  • Giacomo Guido

    Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, BA, Italy

    2 shared publications
  • Luisa Frallonardo

    Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, Bari, 70124, Italy.

    2 shared publications
  • Vincenzo Giliberti

    Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Jonian Area, University of Bari Aldo Moro, Bari, Italy

    2 shared publications
  • Alessandra Vigna

    Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Jonian Area, University of Bari Aldo Moro, Bari, Italy

    1 shared publication

Latest Publications

  • Open Access

    Bloodstream infections caused by multidrug-resistant organisms in patients with and without cancer: clinical outcomes and resistance determinants in a southern Italian cohort

    by Francesco Di Gennaro, Ilenia Annunziata Ritacco, Vincenzo Giliberti, Luisa Frallonardo, Marinella Cibelli, Nicolo De Gennaro, Deborah Fiordelisi, Fabio Signorile, Gaetano Brindicci, Alessia Valenzano, et al.

  • Open Access

    Long-Term Impairment of Working Ability in Subjects under 60 Years of Age Hospitalised for COVID-19 at 2 Years of Follow-Up: A Cross-Sectional Study

    by Luisa Frallonardo, Annunziata Ilenia Ritacco, Angela Amendolara, Domenica Cassano, Giorgia Manco Cesari, Alessia Lugli, Mariangela Cormio, Michele De Filippis, Greta Romita, Giacomo Guido, et al.

    Background: Coronavirus disease 2019 (COVID-19) can lead to persistent and debilitating symptoms referred to as Post-Acute sequelae of SARS-CoV-2 infection (PASC) This broad symptomatology lasts for months after the acute infection and impacts physical and mental health and everyday functioning. In the present study, we aimed to evaluate the prevalence and predictors of long-term impairment of working ability in non-elderly people hospitalised for COVID-19. Methods: This cross-sectional study involved 322 subjects hospitalised for COVID-19 from 1 March 2020 to 31 December 2022 in the University Hospital of Bari, Apulia, Italy, enrolled at the time of their hospital discharge and followed-up at a median of 731 days since hospitalization (IQR 466–884). Subjects reporting comparable working ability and those reporting impaired working ability were compared using the Mann-Whitney test (continuous data) and Fisher’s test or Chi-Square test (categorical data). Multivariable analysis of impaired working ability was performed using a logistic regression model. Results: Among the 322 subjects who were interviewed, 184 reported comparable working ability (57.1%) and 134 reported impaired working ability (41.6%) compared to the pre-COVID-19 period. Multivariable analysis identified age at hospital admission (OR 1.02, 95% CI 0.99 to 1.04), female sex (OR 1.90, 95% CI 1.18 to 3.08), diabetes (OR 3.73, 95% CI 1.57 to 9.65), receiving oxygen during hospital stay (OR 1.76, 95% CI 1.01 to 3.06), and severe disease (OR 0.51, 95% CI 0.26 to 1.01) as independent predictors of long-term impaired working ability after being hospitalised for COVID-19. Conclusions: Our findings suggest that PASC promotes conditions that could result in decreased working ability and unemployment. These results highlight the significant impact of this syndrome on public health and the global economy, and the need to develop clinical pathways and guidelines for long-term care with specific focus on working impairment.